Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
Abstract Background Krabbe disease is a rare neurological disorder caused by a deficiency in the lysosomal enzyme, β-galactocerebrosidase, resulting in demyelination of the central and peripheral nervous systems. If left without treatment, Krabbe disease results in progressive neurodegeneration with...
Main Authors: | Maria L. Beltran-Quintero, Nicholas A. Bascou, Michele D. Poe, David A. Wenger, Carlos A. Saavedra-Matiz, Matthew J. Nichols, Maria L. Escolar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-019-1018-4 |
Similar Items
-
Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature
by: Nicholas A. Bascou, et al.
Published: (2020-10-01) -
Family Attitudes regarding Newborn Screening for Krabbe Disease: Results from a Survey of Leukodystrophy Registries
by: Karlita Blackwell, et al.
Published: (2020-08-01) -
Chronic lithium administration in a mouse model for Krabbe disease
by: Ambra Del Grosso, et al.
Published: (2022-01-01) -
Improved Brain Pathology and Progressive Peripheral Neuropathy in a 15 Year Old Survivor of Infantile Krabbe Disease Treated With Umbilical Cord Transplantation
by: Julia Kofler, et al.
Published: (2022-07-01) -
Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
by: Dietrich Matern, et al.
Published: (2024-01-01)